ClinicalTrials.Veeva

Menu

Surgery for Intravenous Leiomyomatosis (SIVL)

L

Li Yang

Status

Completed

Conditions

Leiomyomatosis

Study type

Observational

Funder types

Other

Identifiers

NCT01707862
GHBeijing-20121012

Details and patient eligibility

About

Intravenous leiomyomatosis (IVL) with intracardiac extension is a rare benign smooth muscle tumor. Reviewing literature, intracardiac extension of the IVL has been reported in at least 70 cases. Most are individual case reports. Surgical experience is not much. However, different opinion of surgical strategies remain controversial. The purpose of this report is to describe our experience of surgical management for the IVL with intracardiac extension.

Full description

All patients underwent surgical management. Clinical data were obtained from medical reports. Following-up was made through email and telephone.

Enrollment

6 patients

Sex

Female

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age more than 18 years.
  • Tumor markers were all within normal limits.
  • Patients underwent surgical management.
  • Patients were followed-up for more than 12 months.

Exclusion criteria

-Tumor markers were all within abnormal limits

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems